PubMed

Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients.

Bodaghi B, Gendron G, Wechsler B, Terrada C, Cassoux N, Huong du LT, Lemaitre C, Fradeau C, LeHoang P, Piette JC.

Br J Ophthalmol. 2007 Mar;91(3):335-9. Epub 2006 Oct 18.PMID: 17050581 [PubMed - indexed for MEDLINE]Related articles

Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease.

Gueudry J, Wechsler B, Terrada C, Gendron G, Cassoux N, Fardeau C, Lehoang P, Piette JC, Bodaghi B.

Am J Ophthalmol. 2008 Dec;146(6):837-44.e1.PMID: 19027420 [PubMed - indexed for MEDLINE]Related articles

Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease.

Wechsler B, Bodaghi B, Huong DL, Fardeau C, Amoura Z, Cassoux N, Piette JC, LeHoang P.

Ocul Immunol Inflamm. 2000 Dec;8(4):293-301.PMID: 11262659 [PubMed - indexed for MEDLINE]Related articles

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.

Kötter I, Zierhut M, Eckstein AK, Vonthein R, Ness T, Günaydin I, Grimbacher B, Blaschke S, Meyer-Riemann W, Peter HH, Stübiger N.

Br J Ophthalmol. 2003 Apr;87(4):423-31.PMID: 12642304 [PubMed - indexed for MEDLINE]Related articlesFree article

Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.

Accorinti M, Pirraglia MP, Paroli MP, Priori R, Conti F, Pivetti-Pezzi P.

Jpn J Ophthalmol. 2007 May-Jun;51(3):191-6. Epub 2007 Jun 7.PMID: 17554481 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of interferon-alpha in the treatment of corticodependent uveitis of paediatric Behcet's disease.

Guillaume-Czitrom S, Berger C, Pajot C, Bodaghi B, Wechsler B, Kone-Paut I.

Rheumatology (Oxford). 2007 Oct;46(10):1570-3. Epub 2007 Aug 16.PMID: 17702770 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.

Kötter I, Eckstein AK, Stübiger N, Zierhut M.

Br J Ophthalmol. 1998 May;82(5):488-94.PMID: 9713053 [PubMed - indexed for MEDLINE]Related articlesFree article

[Behçet's disease: uveitis-therapy with interferon alpha2a - prospective clinical study in 33 patients]

Stübiger N, Kötter I, Deuter C, Zierhut M.

Klin Monbl Augenheilkd. 2001 Dec;218(12):768-73. German. PMID: 11805868 [PubMed - indexed for MEDLINE]Related articles

Results of interferon-alfa therapy in patients with Behçet uveitis.

Tugal-Tutkun I, Güney-Tefekli E, Urgancioglu M.

Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1692-5.PMID: 16673135 [PubMed - indexed for MEDLINE]Related articles

Clinical features of chinese patients with Behçet's disease.

Yang P, Fang W, Meng Q, Ren Y, Xing L, Kijlstra A.

Ophthalmology. 2008 Feb;115(2):312-318.e4. Epub 2007 Aug 10.PMID: 17692378 [PubMed - indexed for MEDLINE]Related articles

[Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a]

Deuter CM, Kötter I, Günaydin I, Zierhut M, Stübiger N.

Ophthalmologe. 2004 Feb;101(2):129-34. German. PMID: 14991308 [PubMed - indexed for MEDLINE]Related articles

Neovascularization of the optic disc in Behçet's disease.

Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Kir N, Urgancioglu M.

Jpn J Ophthalmol. 2006 May-Jun;50(3):256-65.PMID: 16767382 [PubMed - indexed for MEDLINE]Related articles

Treatment of Adamantiades-Behçet disease with systemic interferon alfa.

Zouboulis CC, Orfanos CE.

Arch Dermatol. 1998 Aug;134(8):1010-6.PMID: 9722733 [PubMed - indexed for MEDLINE]Related articles

Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial.

Kötter I, Vonthein R, Zierhut M, Eckstein AK, Ness T, Günaydin I, Grimbacher B, Blaschke S, Peter HH, Stübiger N.

Semin Arthritis Rheum. 2004 Apr;33(5):311-9.PMID: 15079762 [PubMed - indexed for MEDLINE]Related articles

Interferon alpha for ocular Behçet's disease.

Pivetti-Pezzi P, Accorinti M, Pirraglia MP, Priori R, Valesini G.

Acta Ophthalmol Scand. 1997 Dec;75(6):720-2.PMID: 9527339 [PubMed - indexed for MEDLINE]Related articles

Short-term chlorambucil for refractory uveitis in Behcet's disease.

Mudun BA, Ergen A, Ipcioglu SU, Burumcek EY, Durlu Y, Arslan MO.

Ocul Immunol Inflamm. 2001 Dec;9(4):219-29.PMID: 11935432 [PubMed - indexed for MEDLINE]Related articles

Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.

Tognon S, Graziani G, Marcolongo R.

Ann N Y Acad Sci. 2007 Sep;1110:474-84.PMID: 17911463 [PubMed - indexed for MEDLINE]Related articles

A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.

Buggage RR, Levy-Clarke G, Sen HN, Ursea R, Srivastava SK, Suhler EB, Altemare C, Velez G, Ragheb J, Chan CC, Nussenblatt RB, Bamji AT, Sran P, Waldmann T, Thompson DJ.

Ocul Immunol Inflamm. 2007 Mar-Apr;15(2):63-70.PMID: 17558830 [PubMed - indexed for MEDLINE]Related articlesFree article

Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.

Krause L, Altenburg A, Pleyer U, Köhler AK, Zouboulis CC, Foerster MH.

J Rheumatol. 2008 May;35(5):896-903. Epub 2008 Apr 15.PMID: 18412306 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis.

Deuter CM, Kötter I, Günaydin I, Stübiger N, Doycheva DG, Zierhut M.

Br J Ophthalmol. 2009 Jul;93(7):906-13. Epub 2009 Mar 24.PMID: 19321469 [PubMed - indexed for MEDLINE]Related articles